Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)

SHA:603718 Revenue

Shanghai Hile Bio-Technology had revenue of 88.50M CNY in the quarter ending June 30, 2026, with 84.44% growth. This brings the company's total for the last twelve months to 213.98M, down -21.68% year-over-year. In the year 2025, Shanghai Hile Bio-Technology had annual revenue of 187.87M, down -30.69%. That makes Shanghai Hile Bio-Technology the 30,928th largest company in the world by revenue and 5,001st in China.

• Revenue (ttm): 213.98M
• Revenue Growth: -21.68%
• P/S Ratio: 8.67
• Revenue / Employee: 629.37K
• Employees: 340
• Market Cap: 1.88B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medical Instruments 125.48M 66.8%
• Veterinary Biological Products 62.39M 33.2%

By Geography

Chart

• China 187.82M 100.0%
• Foreign 53.56K 0.0%

Fiscal year ended Dec 31, 2025 See the full SHA:603718 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	187.87M	-83.17M	-30.69%
Dec 31, 2024	271.04M	30.32M	12.59%
Dec 31, 2023	240.72M	-59.27M	-19.76%
Dec 31, 2022	299.99M	-47.30M	-13.62%
Dec 31, 2021	347.29M	88.16M	34.02%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error